Ensuring that patients with breast cancer are taking the oral aromatase inhibitors prescribed as follow-up treatment to surgery is an ongoing concern for oncologists.
No takes yet. Share an insight, caveat, or question.
A 2008 study studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: